Hardware FixRecommendedDevice not working? Your driver may be the problemCheck updates for common hardware issues.Fix DriversOctober DealsAmazon USOctober deal check: compare before you payAmazon US: current deals, useful picks and tech finds.Check DealsPC HealthRecommendedCrashes, freezes, slowdowns? Check your PC nowSpot repairable issues before they interrupt work.Check PC×
Skip to content
World desk6 min

Enhanced Humans: What Counts as Enhancement, and What Is Actually Proven?

“Enhanced humans” covers everything from cosmetic procedures and performance drugs to proposed gene and brain interventions. This guide separates established therapeutic uses from speculative upgrades and offers a practical framework for judging evidence, risks, trade-offs and access.

Free tools Windows power users keep installed

One-click scans. No signup required.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

“Enhanced humans” is not a settled technical category. It is an umbrella term for interventions intended to increase a capacity, trait or aspect of well-being, from cosmetic procedures and performance drugs to proposed genetic and neural changes. The key question is not whether an intervention sounds futuristic, but what outcome it targets, for whom, under which conditions, and what evidence shows about benefits, risks and trade-offs.

Some interventions restore lost function and are established forms of care; others aim to move abilities beyond ordinary human ranges and remain experimental or speculative. The boundary between treatment and enhancement depends on contested ideas about health, normality, naturalness and the purpose of medicine.

What “enhanced humans” means

The term covers biomedical interventions that affect bodies or brains, as well as broader tools and practices that extend human capacities. The Stanford Encyclopedia of Philosophy discusses examples including cosmetic surgery; drugs intended to increase athletic strength or endurance; psychopharmaceutical approaches to memory, mood and cognition; and genetic or neurological interventions proposed to affect lifespan, sensory-motor abilities or moral agency.

These examples are not equally mature, safe or effective. A prosthesis that restores movement, a cosmetic operation, an off-label drug and a proposed gene edit belong to very different evidence and regulatory contexts.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.
#1 Best Overall

Therapy and enhancement are not a bright line

Therapy is often described as restoring a capacity lost through disease or injury, while enhancement is described as increasing a capacity beyond a species-typical or medically defined baseline. In practice, neither “normal” nor “healthy” has one uncontested meaning. The same intervention can look restorative for one person and enhancement-oriented for another.

Michael Bess warns against treating the issue as a simple normal-versus-enhanced binary. As he writes in his 2010 analysis, “we need to be aware of the tendency to embed the concept of enhancement within stark binary oppositions that seem perfectly reasonable at first glance, but that in fact yield little more than conceptual muddles if they are not handled carefully.” Read the PubMed record for Bess’s article.

How the main examples differ

The useful comparison is not “natural” versus “unnatural.” It is the intended outcome, the quality of evidence, reversibility, possible harms, access and the effects on a person’s overall well-being.

Example Intended outcome and likely beneficiary What is established Key cautions
Cosmetic surgery Alter appearance for people seeking a chosen physical change No universal outcome or safety profile is established here Risks, expectations, consent and unequal access vary by procedure and setting
Performance-enhancing drugs Increase strength or endurance, particularly in athletic contexts The category is recognized in enhancement ethics; no single drug or benefit claim is established here Potential medical harms, coercive pressure and fairness concerns require intervention-specific evidence
Psychopharmaceutical approaches Change memory, mood or cognition for people seeking a targeted effect Evidence depends on the drug, dose, population and outcome. Pew’s 2016 overview described modest cognitive improvements from off-label modafinil as reported at that time The 2016 account is historical, not current clinical guidance or a recommendation
Brain–machine interfaces Restore or extend sensory-motor or information-processing abilities Pew reported in 2016 that researchers were primarily focused on healing rather than enhancement That was a dated overview; it should not be read as a statement about every current program or as proof of enhancement benefits
Genetic interventions Potentially alter disease risk, lifespan or other traits Enhancement applications remain proposals rather than established routes to general human improvement Heritable effects, uncertain off-target harms, consent and intergenerational justice are major concerns
Neurological interventions Target sensory, motor, cognitive or possibly moral capacities The ethics literature discusses these as possible interventions, not as one proven technology Effects may be difficult to predict, reverse or measure across a whole life

No current, directly comparable prevalence rate for enhancement interventions is established by the cited literature. Opinion percentages should not be treated as adoption figures.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

A practical test for any enhancement claim

Bjørn Hofmann argues that a claim should specify what will become better and provide adequate evidence. His 2017 article states: “Human enhancements that specify what will become better, and provide adequate evidence, are good and should be pursued. Others should not be accepted.” Apply that standard with the following questions.

  1. What capacity is changing? Define the outcome precisely: reaction time, memory recall, endurance, pain, appearance, disease risk or something else. “Smarter” or “better” is not a measurable endpoint.
  2. For whom and in which setting? A result in patients with a diagnosed impairment may not apply to healthy people, children, older adults, workers or elite athletes.
  3. What is the comparator? Compare with ordinary care, rehabilitation, a placebo or no intervention. A gain against baseline may disappear when measured against an effective treatment.
  4. How strong is the evidence? Look for an outcome-specific clinical or experimental record, meaningful effect size, duration of benefit and independently assessed harms. A plausible mechanism is not proof of a useful human result.
  5. Can the effect be reversed? A temporary drug effect, an implanted device and a heritable genetic change have very different recovery and consent implications.
  6. What is traded away? More of one trait can reduce another. Longer life, for example, could mean more years of frailty; a gain in processing speed could carry costs in mood, sleep or judgment. The relevant measure is the person’s overall well-being, not a single high score.
  7. Who can obtain it? Examine price, geography, clinical eligibility, technical infrastructure and whether access would track existing social advantage. Unequal access is a fairness risk to evaluate, not an inevitable result.

Why “more” may not be better

Enhancement debates often assume that a larger quantity of a trait is automatically desirable. The Stanford Encyclopedia of Philosophy highlights cases in which gains conflict: extending lifespan may prolong frailty, while maximizing one capacity can impair another. A meaningful assessment therefore asks whether the intervention improves a person’s life as a whole, over the relevant time horizon.

Questions about authenticity and naturalness also matter to some people, but they do not settle safety or justice. Calling an intervention “natural,” “therapeutic” or “unnatural” cannot substitute for evidence about outcomes, consent and distribution.

Safety, fairness and social pressure

Uncertain and uneven harms

Long-term effects can be difficult to detect, especially when an intervention affects development, reproduction or several body systems. The uncertainty is greatest for proposals that would make durable or heritable changes. Safety judgments must be specific to the intervention and population rather than inferred from a promising mechanism.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Access and competitive pressure

If an enhancement improves performance in school, work or sport, voluntary use can become indirectly compulsory: people may feel they must accept risks to keep up. Fairness analysis should include who sets the standard, who bears side effects and whether non-users are penalized.

Rank #4
Carson Dellosa The 100 Series: Biology Workbook—Grades 6-12 Science, Matter, Atoms, Cells, Genetics, Elements, Bonds, Classroom or Homeschool Curriculum (128 pgs)
  • Great extension activities for science and biology
  • Correlated to standards
  • Comprehensive biology vocabulary study
  • Fascinating true-to-life illustrations

Competing uses of health resources

Spending on enhancement can compete with treatment, prevention and basic care. That does not automatically prohibit enhancement, but it makes opportunity costs part of responsible policy rather than a private consumer decision alone.

Hofmann’s review describes three broad positions: permissive views that generally allow enhancement, prohibitive views that reject it, and restrictive views that permit some uses while imposing justice and safety limits. The article is available from BMC Medical Ethics.

Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Support on Ko-Fi

What public opinion evidence can—and cannot—show

A Pew Research Center survey published July 26, 2016 found that 68% of U.S. adults were “very” or “somewhat” worried about using gene editing on healthy babies to reduce the risk of serious diseases or medical conditions. In the same 2016 report, 66% said they would “definitely” or “probably” not want a brain-chip implant intended to improve their information-processing ability.

What’s actually slowing this PC down?

Pick the symptom - the matching free tool is one click away.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.
Best Value
Human Body Anatomy Busy Book for Kids, Interactive Anatomy Binder
  • 【Content】 Human skeleton, body parts (for both boys and girls), systems, body organs, human systems, heart anatomy, tooth anatomy, human brain, human cells, ear anatomy, eye anatomy, 5 sensory activities.
  • 【Human Anatomy Busy Book】 Discover the secrets of bones, organs and muscles through interactive games and vivid illustrations, making learning enjoyable!
  • 【Unlock the Secrets of the Human Body】 This preschool busy book is an excellent resource for children to understand and appreciate the complexity of the human body and helps stimulate exploratory thinking.
  • 【Travel Toy for Kids】 Our sensory busy book for children. It can be effortlessly placed in your child's school bag. Ideal as a travel toy, school and home learning activity.
  • 【Preschool Busy Book】 Our Human Anatomy Busy Book is a perfect educational tool for preschoolers and lower elementary school students. It offers age-appropriate content and activities to arouse their interest in learning about the human body.

Those are dated U.S. opinion results, not current global attitudes, clinical evidence or adoption rates. They show that concerns about consent, identity and safety were salient at that time; they do not establish what people believe today or whether a technology works.

What would count as responsible progress?

Responsible development starts with a defined, attainable goal and evidence matched to that goal. Researchers and regulators should distinguish restoration from enhancement without pretending the distinction is self-evident; measure benefits and harms over an appropriate period; disclose uncertainty; and include the people who would live with the consequences.

For readers evaluating a new claim, the safest conclusion is provisional: ask for the specific outcome, population, comparator, duration, reversibility and access conditions before calling anyone “enhanced.” Existing therapeutic applications can be valuable without proving that dramatic cognitive or biological upgrades are ready for general use.

Bottom line

Enhanced humans are a field of competing purposes and evidence levels, not a single consumer technology. Judge each intervention by the capacity it targets, the quality of proof, reversibility, whole-life trade-offs, safety and fairness. A label such as “enhancement” should prompt those questions—not answer them.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Quick Recap

Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.

Leave a Reply

Your email address will not be published. Required fields are marked *

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

More from the Wire

  1. Shenzhen desk3 min
    HONOR Expands Beyond Smartphones With Humanoid Robot RevealHONOR said it unveiled its first humanoid robot at MWC 2026 and named shopping assistance, workplace inspections, and supportive companionship as intended uses. Later Robotics D1 claims and a reported…
  2. Cupertino desk5 min
    Apple Unveils AirPods Max 2: The Upgrade That Should Have Happened Years AgoAirPods Max 2 adds H2-powered audio features and Apple claims up to 1.5× more effective ANC, but its design, Smart Case, and 20-hour battery rating are unchanged. Wired lossless audio…
  3. Cupertino desk4 min
    Apple’s OLED Touch MacBooks Are Coming—but the Dynamic Island Is the Real GambleApple has not announced an OLED touchscreen MacBook, but reports point to high-end models arriving in late 2026 or early 2027. The reported Mac Dynamic Island could be useful, but…
Recommended PC Tool
Recommended PC Tool
Windows Errors? Fix Them Before They SpreadFree repair scan
Crashes, No Sound, or Screen Glitches?Free driver scan

Two free Windows tools

One Free Minute Could Fix That PC

Before you go - each of these free tools takes about a minute and tackles what quietly slows a Windows PC down.

Special offer. View Outbyte info, uninstall instructions, EULA, and Privacy Policy.